Form 4: Alignment Healthcare Director Receives Equity Grant

Alignment Healthcare director Jacqueline B. Kosecoff was granted 13,096 restricted stock units, aligning her interests with shareholders.

Summary

• Director Jacqueline B. Kosecoff of Alignment Healthcare, Inc. (ALHC) was granted 13,096 restricted stock units (RSUs) on March 13, 2026.
• Each RSU represents a right to receive one share of the company's Common Stock.
• The grant was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned transaction.
• These RSUs will vest on the one-year anniversary of the grant date, specifically March 13, 2027.
• Vesting is contingent upon Ms. Kosecoff's continued service as a member of the Board of Directors until the vesting date.
• Following this reported transaction, Ms. Kosecoff beneficially owns 303,963 shares of Common Stock (including these RSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents standard director compensation that aligns the director's interests with shareholders, without indicating any significant operational or financial changes.

Positives

• The grant of restricted stock units aligns the director's financial interests with those of the company's shareholders, incentivizing long-term performance.
• Equity compensation is a standard practice for retaining and motivating experienced board members.

Risks

• The 13,096 restricted stock units will be forfeited if Director Jacqueline B. Kosecoff ceases to serve as a member of the Board of Directors prior to the vesting date of March 13, 2027.

Future Outlook

The 13,096 restricted stock units granted to Director Jacqueline B. Kosecoff on March 13, 2026, are scheduled to vest on March 13, 2027, provided she continues her service on the Board of Directors.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units to a director is a common practice in the healthcare and technology sectors, reflecting a broader trend of using equity-based compensation to align executive and board member incentives with long-term shareholder value. This type of compensation is prevalent across publicly traded companies, including peers in the managed care and health technology space.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) for director compensation is a widely accepted practice across industries, including healthcare, aligning with compensation strategies seen at companies like UnitedHealth Group (UNH) and Humana (HUM).
• The vesting schedule, typically one year for director grants, is also standard, providing an incentive for continued service and commitment to the company's strategic objectives.

Related Party Transactions

• The grant of restricted stock units to Director Jacqueline B. Kosecoff constitutes a related party transaction, which is a standard component of director compensation.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of shares upon vesting, but also increased alignment of director incentives with shareholder interests.
• Director (Jacqueline B. Kosecoff): Receives equity compensation, providing a financial incentive for continued service and performance.

Next Steps

• The 13,096 restricted stock units are expected to vest on March 13, 2027, contingent on the director's continued service.

Key Dates

Keywords

Alignment Healthcare, ALHC, Jacqueline B. Kosecoff, Restricted Stock Units, RSU grant, Director compensation, Equity compensation, Form 4, Beneficial ownership, Corporate governance